Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs

Tissue engineering strategies for cartilage regeneration rely on understanding matrix composition and cell behavior. Prior research has shown that chondrocytes and bone marrow stromal cells (BMSCs) can produce extracellular matrix components when cultured in 3D environments. However, it was already known that chondrocytes typically yield higher sulfated glycosaminoglycan (sGAG) content than BMSCs. That uncertainty drove the need to compare PG production and matrix assembly by these two cell types. This gap motivated investigation into whether BMSCs could generate cartilage-like matrices with TGF-beta1 stimulation. No prior work had resolved how BMSC-derived constructs differ in PG composition and pericellular matrix formation. This study aimed to clarify these differences and their implications for engineered cartilage. The findings could help refine cell sources for cartilage tissue engineering. Understanding PG localization and processing is essential for optimizing construct mechanics and function.

This study sought to compare proteoglycan (PG) production and matrix composition between bone marrow stromal cells (BMSCs) and articular chondrocytes (ACs) in a 3D agarose culture system. The specific problem addressed was the lack of clarity on whether BMSCs could generate a PG-rich matrix comparable to ACs when cultured with TGF-beta1. Researchers aimed to determine how PG accumulation and pericellular matrix composition differ between these cell types. They also wanted to assess the role of proteolytic enzymes in construct development. The motivation stemmed from the need to identify optimal cell sources for cartilage tissue engineering. By characterizing PG localization and processing, the study aimed to inform strategies for improving engineered cartilage. This work could guide future efforts to enhance matrix quality in BMSC-derived constructs. The results may help determine the suitability of BMSCs for cartilage regeneration applications.

The study used agarose gels as a 3D culture system for bovine bone marrow stromal cells (BMSCs) and articular chondrocytes (ACs). Cells were isolated from an immature calf and cultured for up to 32 days in the presence of TGF-beta1. Immunofluorescence and histological staining were used to examine PG localization. Researchers tested the effects of aggrecanase and MMP inhibitors on PG accumulation and matrix mechanics. Dynamic moduli were measured to assess construct stiffness. The presence of sulfated glycosaminoglycans (sGAG) was quantified to evaluate matrix production. Pericellular matrix composition was analyzed for collagen VI, decorin, and biglycan. The study compared BMSC and AC constructs cultured under identical conditions. This approach allowed direct comparison of matrix composition and PG processing.

BMSC constructs showed high levels of sulfated glycosaminoglycans (sGAG) and full-length aggrecan. These constructs had low levels of versican compared to articular chondrocyte (AC) constructs. AC constructs contained significantly more collagen II and aggrecan than BMSC constructs. Pericellular matrix of ACs was rich in collagen VI, while BMSCs had higher decorin and biglycan. Aggrecanase inhibition did not affect sGAG accumulation in BMSC constructs. MMP inhibition slightly reduced sGAG accumulation and lowered dynamic moduli. AC constructs exhibited higher mechanical stiffness than BMSC constructs. These findings suggest that BMSCs develop a matrix with some cartilage-like features but differ in composition from AC-derived matrices.

The study found that BMSCs cultured with TGF-beta1 can develop a matrix rich in sulfated glycosaminoglycans (sGAG) and full-length aggrecan. However, BMSC constructs had lower collagen II and aggrecan levels compared to articular chondrocyte (AC) constructs. BMSCs also formed pericellular matrices with less collagen VI and more decorin and biglycan. Aggrecanase inhibition did not significantly alter PG accumulation or matrix stiffness. MMP inhibition slightly reduced sGAG accumulation and moduli. These findings suggest that BMSCs can generate a PG-rich matrix but with distinct composition compared to ACs. The results indicate that PG turnover does not play a major role in BMSC-derived cartilage constructs. The authors propose that BMSCs may still be suitable for cartilage engineering despite these differences.